SAN DIEGO, June 13, 2016 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in New York on behalf of certain purchasers of shares of Express Scripts Holding Company (NASDAQ:ESRX) over alleged Securities Laws Violations by Express Scripts Holding Company.

Investors who purchased shares of Express Scripts Holding Company (NASDAQ:ESRX) have certain options and for certain investors there are short and strict deadlines running. Deadline: July 5, 2016. NASDAQ:ESRX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges that Express Scripts Holding Company repeatedly assured investors that its relationship with Anthem, which is Express Scripts Holding Company’s most important client, remained strong and that it was providing Anthem, and all of its customers, with high quality service. The plaintiff says that Express Scripts Holding Company also touted that it was performing at a high level financially and operationally and that Express Scripts Holding Company addressed the ongoing drug pricing negotiations with Anthem, stating that Express Scripts Holding Company was committed to reaching a mutually beneficial agreement, and continuing its successful working relationship with its most important client.

On January 12, 2016, Anthem publicly threatened to terminate its relationship with Express Scripts Holding Company unless Express Scripts Holding Company would renegotiate its agreement with Anthem to deliver more than $3 billion in annual savings to Anthem. Then, on March 21, 2016, Anthem sued Express Scripts Holding Company alleging that Express Scripts Holding Company breached its contract with Anthem by failing to negotiate drug pricing terms in good faith.

The plaintiff says that that lawsuit revealed a conflict between Express Scripts Holding Company and Anthem dating back to at least February 2015, including allegations that Express Scripts Holding Company was experiencing severe operational problems that interfered with its ability to adequately serve Anthem and exposed Anthem to increased regulatory scrutiny and that investors learned that Anthem would almost certainly either renegotiate its contract to pay billions of dollars less to Express Scripts Holding Company, or worse, seek to engage a competing pharmacy benefit manager resulting in the complete loss of Anthem's business.

Those who purchased Express Scripts Holding Company (NASDAQ:ESRX) shares should contact the Shareholders Foundation, Inc. by e-mail at mail@shareholdersfoundation.com or call +1 (858) 779-1554.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:  
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.